巴楚医学2025，Vol.8Issue(1)：1-11,11.DOI:10.3969/j.issn.2096-6113.2025.01.001
急性髓系白血病的精准诊治
Precision Diagnosis and Treatment of Acute Myeloid Leukemia
摘要
Abstract
Acute myeloid leukemia(AML)is a heterogeneous hematological malignancy.In recent years,with the rapid development and application of various biological techniques,such as flow cytometry,molecular biology and mass spectrometry,people have a deeper understanding of the pathogenesis of AML.The World Health Organization has updated the diagnostic classification of AML several times,and the European Leukemia Network has revised the recommendations for genetic risk stratification of AML.At the same time,great progress has been made in the monitoring of measurable residual disease after treatment,the hierarchical design of treatment regimens,and the application of molecular targeted drugs and immunotherapy.AML has entered the era of more precise diagnosis and treatment.关键词
急性髓系白血病/精准诊治/危险度分层/可检测残留病/分子靶向药物Key words
acute myeloid leukemia(AML)/precise diagnosis and treatment/risk stratification/measurable residual disease/molecular targeted drugs分类
临床医学引用本文复制引用
郑金娥,薛维,杜雯,黄土昂..急性髓系白血病的精准诊治[J].巴楚医学,2025,8(1):1-11,11.基金项目
浙江省科学技术厅应急攻关项目(2022C03189) （2022C03189）
